Vaneck UCITS ETFs plc - VanEck Medical Robotics and Bionic Engineering UCITS ETF (LON:CYBG)

Assets	10.16M
Expense Ratio	n/a
PE Ratio	27.37
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	-5.23%

Volume	476
Open	1,426.80
Previous Close	1,427.80
Day's Range	1,426.80 - 1,426.80
52-Week Low	1,242.91
52-Week High	1,649.50
Beta	n/a
Holdings	33
Inception Date	Dec 2, 2022

About CYBG

CYBO.L was created on 2022-12-02 by VanEck. The fund's investment portfolio concentrates primarily on health care equity. Lobjectif dinvestissement du Fonds est de reproduire, avant les frais et les dpenses, l'indice MVIS Global Bionic Healthcare ESG (l' Indice ).

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: London Stock Exchange
• Ticker Symbol: CYBG
• Provider: VanEck
• Index Tracked: MVIS Global Bionic Healthcare ESG Index - Benchmark TR Net

Performance

CYBG had a total return of -5.23% in the past year, including dividends. Since the fund's inception, the average annual return has been -3.26%.

Top 10 Holdings

65.21% of assets

Name	Symbol	Weight
Medtronic plc	MDT	10.83%
Edwards Lifesciences Corporation	EW	9.68%
Intuitive Surgical, Inc.	ISRG	9.01%
Stryker Corporation	SYK	8.40%
DexCom, Inc.	DXCM	7.83%
Sonova Holding AG	SOON	4.47%
Straumann Holding AG	STMN	4.13%
Zimmer Biomet Holdings, Inc.	ZBH	3.92%
Glaukos Corporation	GKOS	3.52%
Smith & Nephew plc	SNN	3.42%

Data Sources: S&P Global Market Intelligence and Finnhub

Historical data is provided by S&P Global Market Intelligence. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error